123 related articles for article (PubMed ID: 6893465)
1. Failure of folic acid (pteroylglutamic acid) to affect hyperuricemia.
Boss GR; Ragsdale RA; Zettner A; Seegmiller JE
J Lab Clin Med; 1980 Nov; 96(5):783-9. PubMed ID: 6893465
[TBL] [Abstract][Full Text] [Related]
2. Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
Zhao X; Zhu JX; Mo SF; Pan Y; Kong LD
J Ethnopharmacol; 2006 Feb; 103(3):357-65. PubMed ID: 16182482
[TBL] [Abstract][Full Text] [Related]
3. Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
Zhu JX; Wang Y; Kong LD; Yang C; Zhang X
J Ethnopharmacol; 2004 Jul; 93(1):133-40. PubMed ID: 15182918
[TBL] [Abstract][Full Text] [Related]
4. Reducing effect of mangiferin on serum uric acid levels in mice.
Niu Y; Lu W; Gao L; Lin H; Liu X; Li L
Pharm Biol; 2012 Sep; 50(9):1177-82. PubMed ID: 22881143
[TBL] [Abstract][Full Text] [Related]
5. [Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
Royer R; Vindel J; Lamarche M; Kissel P
Presse Med (1893); 1968 Dec; 76(49):2325-7. PubMed ID: 5737250
[No Abstract] [Full Text] [Related]
6. Antihyperuricemic properties of amflutizole in gout.
Wortmann RL; Ridolfo AS; Lightfoot RW; Fox IH
J Rheumatol; 1985 Jun; 12(3):540-3. PubMed ID: 3900392
[TBL] [Abstract][Full Text] [Related]
7. A long-term study of the absorption of large oral doses of folic acid.
Zettner A; Boss GR; Seegmiller JE
Ann Clin Lab Sci; 1981; 11(6):516-24. PubMed ID: 7325593
[TBL] [Abstract][Full Text] [Related]
8. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice.
Wang Y; Zhu JX; Kong LD; Yang C; Cheng CH; Zhang X
Basic Clin Pharmacol Toxicol; 2004 May; 94(5):232-7. PubMed ID: 15125693
[TBL] [Abstract][Full Text] [Related]
9. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Palo WA; Eustace D; Vernillet L; Joseph-Ridge N
Arthritis Rheum; 2005 Mar; 52(3):916-23. PubMed ID: 15751090
[TBL] [Abstract][Full Text] [Related]
10. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice.
Kong LD; Yang C; Ge F; Wang HD; Guo YS
J Ethnopharmacol; 2004 Aug; 93(2-3):325-30. PubMed ID: 15234772
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic and pharmacodynamic analysis of pegloticase in subjects with hyperuricemia and treatment-failure gout.
Yue CS; Huang W; Alton M; Maroli AN; Waltrip RW; Wright D; Marco MD
J Clin Pharmacol; 2008 Jun; 48(6):708-18. PubMed ID: 18420531
[TBL] [Abstract][Full Text] [Related]
12. Hereditary nephropathy associated with hyperuricemia and gout.
Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
[TBL] [Abstract][Full Text] [Related]
13. [Effects of processing Phellodendron amurense with salt on anti-gout].
Yang C; Zhu JX; Wang Y; Wen YL; Kong LD
Zhongguo Zhong Yao Za Zhi; 2005 Jan; 30(2):145-8. PubMed ID: 15714822
[TBL] [Abstract][Full Text] [Related]
14. Effect and mechanism of total saponin of Dioscorea on animal experimental hyperuricemia.
Chen GL; Wei W; Xu SY
Am J Chin Med; 2006; 34(1):77-85. PubMed ID: 16437741
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents.
Murugaiyah V; Chan KL
J Ethnopharmacol; 2009 Jul; 124(2):233-9. PubMed ID: 19397979
[TBL] [Abstract][Full Text] [Related]
16. Hypouricemic action of diflunisal in gouty patients: in vitro and in vivo studies.
Ferraccioli G; Spisni A; Ambanelli U
J Rheumatol; 1984 Jun; 11(3):330-2. PubMed ID: 6547486
[TBL] [Abstract][Full Text] [Related]
17. Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers.
Becker MA; Kisicki J; Khosravan R; Wu J; Mulford D; Hunt B; MacDonald P; Joseph-Ridge N
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1111-6. PubMed ID: 15571211
[TBL] [Abstract][Full Text] [Related]
18. Effect of prednisolone on urate and oxypurine excretion.
Hisatome I; Ishiko R; Sasaki N; Kotake H; Kobayashi M; Ogino K; Hasegawa J; Yoshida A; Shigemasa C; Mashiba H
Horm Metab Res; 1991 Oct; 23(10):513-4. PubMed ID: 1761287
[No Abstract] [Full Text] [Related]
19. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
Torres RJ; Prior C; Puig JG
Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
